Accéder au contenu
Merck

FGF10: Type III Epithelial Mesenchymal Transition and Invasion in Breast Cancer Cell Lines.

Journal of Cancer (2014-07-25)
Ali Abolhassani, Gholam Hossein Riazi, Ebrahim Azizi, Saeid Amanpour, Samad Muhammadnejad, Mahnaz Haddadi, Ali Zekri, Reza Shirkoohi
RÉSUMÉ

Fibroblastic growth factor-10 (FGF-10) has an important role in type I epithelial mesenchymal transition (EMT) during the embryonic period of life (gastrulation). Since EMT has a critical role during cancer cells invasion and metastasis (type III) this study sought to investigate the possible role of FGF-10 in type III EMT by monitoring breast cancer cell lines' behavior by FGF-10 regulation. MCF-7 and MDA-MB-231 cell lines with different levels of FGF10 expression were treated with FGF-10 recombinant protein and FGF-10 siRNA, respectively. The cell viability, migration, colony formation and wound healing have a direct relationship with FGF-10 expression, while FGF-10 expression decreased apoptosis. All mesenchymal factors (such as vimentin, N cadherin, snail, slug, TGF-β) increased due to FGF-10 expression with contrary expression of epithelial markers (such as E-cadherin). Moreover, GSK3β phosphorylation (inactivation) increased with FGF-10 expression. The important role of FGF-10 in type III EMT on cancer cells and initiation of metastasis via various kinds of signaling pathways has been suggested.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Roche
Kit de prolifération cellulaire I (MTT)